KRAS and neoplasm: In the A549 xenografted mice, the treatment with αEGFR-mAB-P/KRAS-siRNA/P nanostructures led to significantly reduced tumour growth compared to control-siRNA loaded αEGFR-mAB-P/P nanostructures (Fig. 6B).